Abstract: A patient-worn arrhythmia monitoring and treatment device weight between 250 grams and 2,500 grams includes at least one contoured pad configured to be adhesively coupled to a patient's torso, a plurality of therapy electrodes, at least one of which is integrated with the at least one contoured pad, and a plurality of ECG sensing electrodes, at least one of which is integrated with the at least one contoured pad. At least one housing configured to form a watertight seal with the at least one contoured pad extends no more than 5 cm from the contoured pad. A processor disposed within the housing is coupled to a therapy delivery circuit and configured to detect one or more treatable arrhythmias based on at least one ECG signal and cause a therapy delivery circuit to deliver at least one defibrillation pulse on detecting the one or more treatable arrhythmias.

Abstract: Disclosed examples include those directed to detecting and remediating detachment of electrodes from a patient. In an example, a system calculates a Pearson correlation coefficient between: (1) power spectral density of the noise and (2) power spectral density of a recorded signal (e.g., from an electrode being operated in free-run EMG mode). If the recorded signal correlates with the noise, then the system notifies the user of presence of noise (e.g., the fallen electrode). Otherwise, the recorded signal is considered as the signal of interest (e.g., a valid EMG signal).

Abstract: One or more antennas are electrically coupled to one or more switches of an implantable medical device (IMD) in which the one or more switches are additionally electrically coupled to one or more lead wires of an IMD lead. The one or more switches also are electrically coupled to one or more electrodes or electrical circuitry of the IMD's implantable pulse generator (IPG). In response to exposure of the IMD to an energetic electromagnetic field, a voltage signal is induced in the one or more antennas and provided, possibly via one more filters, as a control signal to the one or more switches. Receipt of the control signal by the one or more switches automatically configures the one or more switches into a non-conductive state, thereby electrically isolating the one or more lead wires from the one or more electrodes or the IPG electrical circuitry.

Abstract: A method for mining an entity focus in a text may include: performing word and phrase feature extraction on an input text; inputting an extracted word and phrase feature into a text coding network for coding, to obtain a coding sequence of the input text; processing the coding sequence of the input text using a core entity labeling network to predict a position of a core entity in the input text; extracting a subsequence corresponding to the core entity in the input text from the coding sequence of the input text, based on the position of the core entity in the input text; and predicting a position of a focus corresponding to the core entity in the input text using a focus labeling network, based on the coding sequence of the input text and the subsequence corresponding to the core entity in the input text.

Abstract: A system to induce electrical muscle relaxation for airway management. The illustrative system includes a power control system targeted to relax muscles associated with an airway channel, and more particularly, to assist in human intubation by placement of an endotracheal tube within the trachea of a patient, mask ventilation, and/or resolution of laryngospasm. The relaxation of the muscles is achieved through external stimulation of nerves through the skin by an output electrical current pattern applied by the power control system. The illustrative system is configured to independently regulate an output current frequency and an output current amplitude of the output electrical current pattern.

Abstract: A neurostimulation system is disclosed for providing treatment to a patient during a therapy session. The neurostimulation system includes a neurostimulator for transmitting magnetic or electrical signals based upon a treatment program. A programmer is connected to the neurostimulator to set a treatment session parameter value to calculate a therapy compliance value. A compliance module is connected to the neurostimulator and the programmer to calculate and store a therapy compliance value. A control module is connected to the compliance module, the programmer and the neurostimulator and determines whether the therapy compliance value is within a range of the treatment program. The neurostimulator transmits electrical or magnetic signals to the patient in a treatment session only if the therapy compliance value meets a compliance criteria.

Abstract: Nerve stimulation systems and methods are disclosed for providing improved compliance of a patient to a pelvic disorder treatment regimen. A patient interface module is connected to a control module for providing compliance information related to compliance criteria for a set of scheduled events. Patient compliance is assessed and notification or treatment events can be scheduled, rescheduled or otherwise adjusted based upon patient compliance or non-compliance according to compliance rules and parameters of a treatment compliance module. Both compliance and non-compliance may lead to adjustment of the treatment regimen, scheduled treatment events, and notifications to the patient or user operating the nerve stimulation system.

Abstract: Systems and methods provide interface to a patient's autonomic nerves via an interior lumen wall of a blood vessel. Systems can include a probe having at least one electrode for receiving electrical signals from the interior of the lumen wall. The system can include processing components for extracting the signals from noise within the patient's body. Systems can include stimulation electrodes for providing stimulation and eliciting action potentials within the patient and destructive processes for destroying nervous function. The effect of nerve destruction on the propagation of action potentials can be effectively used as a feedback mechanism for determining the amount of nervous function destruction in the patient.

Abstract: A micro-scale implantable bioelectronic medical device system that allows multichannel neurostimulation of peripheral nerve bundles so to affect a more localized and specific control over neuromodulation of body tissues and organs. Such systems can be used in medical therapeutic applications for the treatment of a wide variety of disorders of the human body and may be applied in the growing field of medical neuromodulation. Systems and processes may also provide a way of interfacing to nerve and muscle for purposes of the control of advanced robotic prosthetics as well as man-machine interfaces. Apparatus, systems and processes may be adapted in various embodiments to the stimulation of brain and other bioelectrically excitable tissues in the human body as well.

Abstract: A device with a keypad that includes a bezel assembled with a flexible substrate is provided. The bezel comprises: a first aperture and a second aperture separated by a retention plate. The flexible substrate comprises two or more arms joined at joining ends, and separated at distal ends, distal from the joining ends; at least one arm, of the two or more arms, comprises: a first button portion and a second button portion configured to respectively mate with the first aperture and the second aperture from a rear-side of the bezel, the first button portion and the second button portion separated by a non-button portion. The flexible substrate may be assembled with the bezel to form the keypad by inserting a distal end of the one or more arms through the first aperture from the rear-side of the bezel.

Abstract: Waveforms for a stimulator device, and methods and circuitry for generating them, are disclosed having high- and low-frequency aspects. The waveforms comprise a sequence of pulses issued at a low frequency which each pulse comprising first and second charge-balanced phases. One or both of the phases comprises a plurality a monophasic sub-phase pulses issued at a high frequency in which the sub-phase pulses are separated by gaps. The current during the gaps in a phase can be zero, or can comprise a non-zero current of the same polarity as the sub-phase pulses issued during that phase. The disclosed waveforms provide benefits of high frequency stimulation such as the promotion of paresthesia free, sub-threshold stimulation, but without drawbacks inherent in using high-frequency biphasic pulses.

Abstract: An external device for use with an implantable medical device includes circuitry that is configured to drive a coil to produce a static electromagnetic field to change a status of the implantable medical device. The static electromagnetic field may replace a physical magnet, which may not be commonly carried by a patient, to induce an emergency shutdown of the implantable medical device. The external device may be a charger or controller that is used to charge or communicate with the implantable medical device, and the coil may primarily be used for those charging and telemetry functions in such devices.

Abstract: A surgical tool including first connecting elements, contacting elements, and conductive elements. The contacting elements are configured to contact nerve tissue of a patient. The conductive elements extend from the connecting elements to the contacting elements. The conductive elements have respective insulative outer layers. The insulative outer layers isolate the conductive elements from each other. The first connecting elements are configured to connect to and receive monophasic stimulation pulses from second connecting elements on a modular stimulation module. The modular stimulation module is configured to connect to the tool and other tools via the second connecting elements. The conductive elements are configured to transfer the monophasic stimulation pulses from the connecting elements to the contacting elements.

Abstract: Nerve stimulation systems and methods are disclosed for providing improved compliance of a patient to a therapy regimen. Patient compliance is assessed and notification or treatment events can be scheduled, rescheduled or otherwise adjusted based upon patient compliance or non-compliance according to compliance rules and parameters of a treatment compliance module. Both compliance and non-compliance may lead to adjustment of the treatment regimen, scheduled treatment events, and notifications. Gamification of the treatment regimen allows users to obtain points that may be used to receive virtual awards, status awards, or monetary compensation of various forms. Monitoring of usage and compliance can be managed both locally and remotely from the user. Stimulation treatment, compliance monitoring, and gamification is disclosed for treatments using external or implanted stimulators, or the combination.

Abstract: A hermetically sealed filtered feedthrough assembly includes an electrically conductive ferrule sealed by a first gold braze to an insulator disposed at least partially within a ferrule opening. A conductive wire is disposed within a via hole disposed through the insulator extending from a body fluid side to a device side. A second gold braze hermetically seals the conductive leadwire to the via hole. A capacitor is disposed on the device side having a capacitor dielectric body with a dielectric constant k that is greater than 0 and less than 1000. The capacitor is the first filter capacitor electrically connected to the conductive leadwire coming from the body fluid side into the device side. An active electrical connection electrically connects the conductive leadwire to the capacitor active metallization. A ground electrical connection electrically connects the capacitor ground metallization to the ferrule and housing of the active implantable medical device.

Abstract: To provide a compact, high density, highly reliable and low cost three-terminal IC sensor unit, a host device to be connected to the sensor unit, a sensor system comprising such sensor unit and host device and a communication method between sensor unit and host device. The power supply voltage to be supplied to the sensor unit 100 from the host device (external device) 200 through the power supply terminal 101 is turned on/off by power supply on/off means 220 in response to command and/or data to be transmitted and such on/off pulsation of the power supply voltage is detected by the data detection section 140 for transmission from the host device 200 to the sensor unit 100. Also, the current source 160 in the sensor unit 100 varies the load current of the power supply in the host device 200 through the power supply terminal 101 in response to the data and the change in the load current is detected by the current detection section 230 for data transmission from the sensor unit 100 to the host device 200.

Abstract: A method for generating a signal shape (w1) for an electro-stimulation signal (w1) for healing wounds by electro-stimulation by way of an electrode (E1) which has an encoding member (6) with a code word (cw) which identifies therapeutic treatments, and is coupled to indicators (i1, i2) which indicate which treatments have to be activated. The signal shape (w1) is formed systematically from base signals capable of being parameterized such as a DC signal and two pulse trains, the parameters and the timing of which are formed systematically and applied where necessary, in accordance with the combined therapies. The generation of signal shapes for a plurality of electrodes is also disclosed.

Abstract: An automated EP analysis apparatus for monitoring, detecting and identifying changes (adverse or recovering) to a physiological system generating the analyzed EPs, wherein the apparatus is adapted to characterize and classify EPs and create alerts of changes (adverse or recovering) to the physiological systems generating the EPs if the acquired EP waveforms change significantly in latency, amplitude or morphology.

Abstract: A device includes a housing, a first magnetic field sensor, a second magnetic field sensor, and a control module. The housing is configured to be implanted in a patient. The first magnetic field sensor is located at a first location within the housing and is configured to measure a first strength of a magnetic field at the first location. The second magnetic field sensor is located at a second location within the housing and is configured to measure a second strength of the magnetic field at the second location. The control module is configured to identify a source of the magnetic field based on the first and second strengths.

Abstract: Apparatus for providing transcutaneous electrical nerve stimulation (TENS) therapy to a user, the apparatus comprising: a stimulation unit for electrically stimulating at least one nerve of the user; an electrode array connectable to the stimulation unit, the electrode array comprising a plurality of electrodes for electrical stimulation of the at least one nerve of the user; a monitoring unit electrically connected to the stimulation unit for monitoring the on-skin status of the electrode array; an analysis unit for analyzing the on-skin status of the electrode array to determine the effective on-skin time of the electrode array; and a feedback unit for alerting the user when the analysis unit determine that the effective on-skin time exceeds a threshold.

Abstract: An electrical stimulation system includes a lead or lead extension; a control module coupleable to the lead or lead extension; and a continuous conductive RF shield having a first portion extending along at least a portion of the lead and a second portion configured and arranged to form a perimeter band disposed around the housing of the control module. Alternatively, an electrical stimulation lead or lead extension includes a body; first contacts disposed along the distal end portion of the body; second contacts disposed along the proximal end portion of the body; a conductive RF shield disposed over, and extending along, at least a portion of the body; and a non-conductive jacket disposed over the conductive RF shield. The non-conductive jacket defines at least one window which exposes a portion of the conductive RF shield radially beneath the at least one window.

Abstract: An implantable medical device including at least one elongate electrical line with a first electrical component as a functional conductor, and at least one second electrical component with an electrical length. The first electrical component includes a proximal end and a distal end, wherein the distal side is in electrical contact with tissue or blood. The first electrical component is in electrical contact with the at least one second electrical component, and wherein the electrical length of the at least one second component corresponds to at least a tenth of a wavelength (?/10) of electromagnetic waves in a radiofrequency range.

Abstract: An implantable cardiac device that detects and protects against strong magnetic fields produced by MRI equipment is disclosed. The device has a magnetic field sensor for detecting the presence of a relatively weak static magnetic field (102, 110, 118, 122) of a level equivalent to that of a permanent magnet in the vicinity of the device. The device is switched from a standard operating mode (100) where the nominal functions of the device are active, to a specific protected MRI mode (114, 116) in the presence of a magnetic static field of a level corresponding to that emitted by MRI equipment. The device further temporarily switches the device from the standard operating mode (100) to an MRI stand-by state (108) when a magnetic field is detected by the magnetic field sensor such that a subsequent detection of a magnetic field switches the device from an MRI stand-by state to the specific protected MRI mode.

Abstract: A method for operating a magnetic resonance apparatus by a safety unit, taking into account persons fitted with an implant, a safety unit, a safety system, a magnetic resonance apparatus, and a computer program product are provided. The magnetic resonance apparatus includes a first part and a second part. The first part is operated separately from the second part and includes the safety unit. During an examination of a person fitted with an implant, the safety unit checks that the magnetic resonance apparatus, in a restricted operating mode, is complying with implant-conformant limit values.

Abstract: Implantable medical systems include implantable medical leads that have magnetic orientation-independent magnetically actuated switches that are placed in the conduction path to the electrode of the lead. Thus, regardless of the orientation of a substantial magnetic field like that from an MRI machine to the lead and switch within the lead, the switch opens when in the presence of that substantial magnetic field. The switch may be placed in close proximity to the electrode such that the opening of the switch disconnects the electrode from the majority of the conduction path which thereby produces a high impedance for RF current and reduces the amount of heating that may occur at the electrode when in the presence of substantial levels of RF electromagnetic energy as may occur within an MRI machine.

Abstract: An electronic stimulator device comprises a battery, first and second output ports, and an energy discharge circuit. The energy discharge circuit is coupled to the battery and configured to receive an electrical charge from the battery and deliver the electrical charge through an energy output port. A first switch is connected between the energy output and the first output port. A second switch is connected between the second output port and electrical ground. A third switch is connected between the second output port and the energy output. A fourth switch is connected between the first output port and electrical ground. A controller comprising a processor is configured to actuate the first, second, third and fourth switches between open and close states to deliver a biphasic current pulse between the first and second output ports.

Abstract: The present invention relates to a high voltage switch circuit, comprising an input port adapted to receive a pulse type input current and an output port, which can be used selectively to conduct an output current to a corresponding electrical load. The switch circuit comprises a buffer stage adapted to sense the input voltage at said input port and to provide a buffered voltage that follows said input voltage. The switch circuit comprises complementary switches electrically connected between said input port and said output port and a voltage level translator electrically connected with said switches, said buffer stage and a control terminal that provides a control signal. The voltage level translator provides suitable gate voltages at the gate terminals of said switches, so that the operation of these latter can be controlled by said control signal.

Abstract: Embodiments include an implantable device configured to be used in an MRI device, including a control unit, a memory unit, an MRI sensor and a statistics unit. The memory unit includes program information including control programs and/or control parameters that control the function of the control unit, and current state parameters. The MRI sensor is connected to the control unit and responds to a positioning of the implant and/or a patient within or in the immediate vicinity of the MRI device. The statistics unit is connected to the control unit and detects current state parameters present prior to a respective response of the MRI sensor. The control unit selects a control program or control parameters indicated by the state parameters and maintains the control program or control parameters until the MRI sensor indicates a positioning of the implantable device within or in the immediate vicinity of the MRI device.

Abstract: Implantable medical systems include implantable medical leads that have magnetic orientation-independent magnetically actuated switches that are placed in the conduction path to the electrode of the lead. Thus, regardless of the orientation of a substantial magnetic field like that from an MRI machine to the lead and switch within the lead, the switch opens when in the presence of that substantial magnetic field. The switch may be placed in close proximity to the electrode such that the opening of the switch disconnects the electrode from the majority of the conduction path which thereby produces a high impedance for RF current and reduces the amount of heating that may occur at the electrode when in the presence of substantial levels of RF electromagnetic energy as may occur within an MRI machine.

Abstract: An implantable medical device may comprise a therapy module configured to generate pacing therapy for a heart of a patient and a control module configured to control the therapy module. The control module may also be configured to detect a condition indicative of the presence of a magnetic resonance imaging (MRI) device and switch operation from a first pacing therapy program to a second pacing therapy program in response to detecting the condition indicative of the presence of the MRI device. While operating in the second pacing therapy program, control module may control the therapy module to generate a pacing pulse to an atrium of the heart of the patient during a time period between the end of an atrial refractory period of a previous atrial depolarization and the end of a ventricular refractory period of a previous ventricular depolarization corresponding to the previous atrial depolarization.

Abstract: A neurostimulation device capable of being placed between a stimulation state and an EMI protection state. The neurostimulation device comprises a plurality of electrical terminals configured for being respectively coupled to a plurality of stimulation electrodes, stimulation output circuitry configured for being selectively activated during the stimulation state to output a plurality of stimulation pulses to the plurality of electrical terminals, electromagnetic protection circuitry configured for being selectively activated during the EMI protection state to prevent at least a portion of the electrical current induced on at least one of the electrical terminals by an electromagnetic field entering the stimulation output circuitry, and a controller configured for automatically defaulting the neurostimulation device to the EMI protection state.

Abstract: An imaging apparatus and a method of controlling the same are disclosed. The imaging apparatus control method includes generating a pulse signal to an imaging unit, the imaging unit imaging an object to acquire an image signal of the object, generating an antiphase pulse signal based on the generated pulse signal, the antiphase pulse signal having an opposite phase to that of the pulse signal, and controlling a wireless communication unit based on the antiphase pulse signal, the wireless communication unit transmitting the image signal using a wireless communication network.

Abstract: An active implantable medical device (AIMD) for use with a medical lead carrying at least one lead electrode. The AIMD comprises interior electronic circuitry configured for performing a medical function via the medical lead, an electrically conductive case containing the interior electronic circuitry, at least one electrical terminal configured for electrically coupling the electronic circuitry respectively to the lead electrode(s), and an inductive element coupled in series between the electrical terminal(s) and the case. The inductive element is configured for hindering the shunting of electrical current from the at least one electrical terminal to the case that has been induced by electromagnetic interference (EMI) impinging on the medical lead.

Abstract: A method for configuring stimulation pulses in an implantable stimulator device having a plurality of electrodes is disclosed, which method is particularly useful in adjusting the electrodes by current steering during initialization of the device. In one aspect, a set of ideal pulses for patient therapy is determined, in which at least two of the ideal pulses are of the same polarity and are intended to be simultaneous applied to corresponding electrodes on the implantable stimulator device during an initial duration. These pulses are reconstructed into fractionalized pulses, each comprised of pulse portions. The fractionalized pulses are applied to the corresponding electrodes on the device during a final duration, but the pulse portions of the fractionalized pulses are not simultaneously applied during the final duration.

Abstract: An RF protection circuit mitigates potentially adverse effects that may otherwise result from electromagnetic interference (e.g., due to MRI scanning of a patient having an implanted medical device). The RF protection circuit may comprise a voltage divider that is deployed across a pair of cardiac electrodes that are coupled to internal circuitry of the implantable medical device. Each leg of the voltage divider may be referenced to a ground of the internal circuit, whereby the different legs are deployed in parallel across different circuits of the internal circuitry. In this way, when an EMI-induced (e.g., MRI-induced) signal appears across the cardiac electrodes, the voltages appearing across these circuits and the currents flowing through these circuits may be reduced. The RF protection circuit may be used in an implantable medical device that employs a relatively low capacitance feedthrough to reduce EMI-induced (e.g., MRI-induced) current flow in a cardiac lead.

Abstract: A lead for an implantable cardiac prosthesis is disclosed. The lead has integrated protection against the effects of magnetic resonance imaging (“MRI”) fields. A protection circuit (26) may be placed at the distal end of the lead comprises a resistive component (28) interposed between the electrode (E1, E2) and the distal end of the conductor (22, 24) associated with this electrode. A normally-open controlled active switch (34, 36) may allow in its closed state to short-circuit the resistive component. A control stage (32) may be coupled to the conductors and detect the voltage of a stimulation pulse applied on the conductor(s), and selectively control by this voltage the closing of the active switch for a duration at least equal to the duration of detected stimulation pulse.

Abstract: Grounding of a shield that is located in an implantable medical lead may be done in many ways. The ground pathway may couple to the shield at a point that is outside of a header of an implantable medical device to which the implantable medical lead is attached. The ground pathway may couple to the shield at a point that is within the header of the implantable medical device. The ground pathway may terminate at the metal can of the implantable medical device. As another option, the ground pathway may terminate at a ground plate that is mounted to the header. The ground pathway may be direct current coupled from the shield to the can or ground plate. Alternatively, the ground pathway may include one or more capacitive couplings that provide a pathway for induced radio frequency current.

Abstract: A surgical device is disclosed, and includes a pair of finger-mountable annular members, each having an electrode disposed thereon. An optical member is disposed on at least one of the pair of finger-mountable annular members and has a first set of light transmitting properties corresponding to a first set of physical parameters of at least one of the finger-mountable annular members. At least one finger-mountable annular member is configured to transition to a second set of physical parameters being different from the first set of physical parameters. The optical member is configured to transition from a first set of light transmitting properties to a second set of light transmitting properties, the second set of light transmitting properties corresponding to the second set of physical parameters, the second set of light transmitting properties being different from the first set of light transmitting properties.

Abstract: The electric device for producing successive positive and negative electric charges includes a thyristor-based electrical pulse generator for providing alternating positive and negative pulses with relatively small currents. The potential alternates between positive and negative charge current, and the small current is applied, in the form of sparks, to a body under treatment. A cup-shaped electrode is mounted in the distal end of a handle for application to the body. The treatment device is carried in a case for portability.

Abstract: A composite RF current attenuator for a medical lead includes a conductor having a distal electrode contactable to biological cells, a bandstop filter in series with the lead conductor for attenuating RF currents flow through the lead conductor at a selected center frequency or across a range of frequencies about the center frequency, and a lowpass filter in series with the bandstop filter and forming a portion of the lead conductor. The bandstop filter has a capacitance in parallel with a first inductance. In a preferred form, the lowpass filter includes a second inductance in series with the bandstop filter, wherein the values of capacitance and inductances for the composite RF current attenuator are selected such that it attenuates MRI-induced RF current flow in an MRI environment.

Abstract: Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache. The disclosed methods may also be used to treat other disorders that may be co-morbid with migraine headaches, such as anxiety disorders. In preferred embodiments of the disclosed methods, one or both of the patient's vagus nerves are stimulated non-invasively. In other embodiments, parts of the sympathetic nervous system and/or the adrenal glands are stimulated.

Abstract: A housing for an electrostimulation device comprising a charger plug and a stimulation plug, designed to receive respectively a connector linked to a charger and a connector linked to a stimulation electrode, characterized in that it comprises a mobile locking element designed to alternately lock the charger plug or the stimulation plug.

Abstract: An energy management system that facilitates the transfer of high frequency energy induced on an implanted lead or a leadwire includes an energy dissipating surface associated with the implanted lead or the leadwire, a diversion or diverter circuit associated with the energy dissipating surface, and at least one switch disposed between the diversion circuit and the AIMD electronics for diverting energy in the implanted lead or the leadwire through the diversion circuit to the energy dissipating surface. The switch may comprise a single or multi-pole double or single throw switch. The diversion circuit may be either a high pass filter or a low pass filter.

Abstract: An implantable medical assist device includes a medical device. The medical device has a housing and electronics contained therein. A lead provides an electrical path to or from the electronics within the medical device. A resonance tuning module is located in the housing and is connected to the lead. The resonance tuning module includes a control circuit for determining a resonant frequency of the implantable medical assist device and an adjustable impedance circuit to change the combined resonant frequency of the medical device and lead.

Abstract: An overvoltage protection element, provided as a component of a medical device (3) used on or in a human or animal body, reduces power absorption upon application of an external overvoltage signal having chronological rising and/or decay characteristic at an interface (15) of the medical device (3). The overvoltage protection element has reshaping means (17) which convert the external overvoltage signal at the interface (15) into an internal voltage pulse, and limiting means (19) which limit a voltage drop on at least one electronic component of the medical device to a predetermined limiting value.

Abstract: A medical device lead includes a lead body having a proximal end and a distal end. The proximal end is configured for connection to a pulse generator. One or more electrodes are at a distal end of the lead body, and a lead conductor extends through the lead body and is electrically coupled to at least one of the one or more electrodes. The conductor is configured to deliver electrical signals between the proximal end and the at least one of the one or more electrodes. A sacrificial conductor extends through the lead body adjacent to lead conductor and is configured to fail at a lower stress than the lead conductor.

Abstract: Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache. The disclosed methods may also be used to treat other disorders that may be co-morbid with migraine headaches, such as anxiety disorders. In preferred embodiments of the disclosed methods, one or both of the patient's vagus nerves are stimulated non-invasively. In other embodiments, parts of the sympathetic nervous system and/or the adrenal glands are stimulated.

Abstract: A neural stimulation system includes a safety control system that prevents delivery of neural stimulation pulses from causing potentially harmful effects. The neural stimulation pulses are delivered to one or more nerves to control the physiological functions regulated by the one or more nerves. Examples of such harmful effects include unintended effects in physiological functions associated with autonomic neural stimulation and nerve injuries caused by excessive delivery of the neural stimulation pulses.

Abstract: An apparatus is disclosed for providing efficient stimulation. As an example, a variable compliance regulator can be connected to supply a compliance voltage to a power supply rail, which compliance voltage can vary dynamically based on a stimulus waveform. A pulse generator can be configured to provide an output waveform to one or more output based on the stimulus waveform for delivery of electrical therapy.

Abstract: Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache. The disclosed methods may also be used to treat other disorders that may be co-morbid with migraine headaches, such as anxiety disorders. In preferred embodiments of the disclosed methods, one or both of the patient's vagus nerves are stimulated non-invasively. In other embodiments, parts of the sympathetic nervous system and/or the adrenal glands are stimulated.